Vor Bio to Participate in the Stifel 2024 Healthcare Conference

CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host 1x1 investor meetings at the Stifel 2024 Healthcare Conference.

Stifel 2024 Healthcare Conference
Fireside Chat: Monday, November 18, 2024 at 2:25 pm ET
Location: New York, NY

A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
[email protected]

You May Also Be Interested In

• BNP PARIBAS GROUP: SUDAN LITIGATION STATEMENT FROM BNP PARIBAS
• 5 Top Meme Coins Before September: Could Apeing’s Upcoming Crypto Presale Make the Biggest Splash in the Meme Coin Market? 
• Small Business, Big Trust: How Local Locksmiths Compete With National Call Centers